Lipoprotein storage disorders emerge as a heterogeneous group of rare metabolic diseases. These conditions are characterized by the accumulation of abnormal lipoproteins, primarily within the tissues, leading to a spectrum of clinical presentations. The underlying pathophysiology involve defects in the processing of apolipoproteins or enzymes invol